Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasgrowth-development-and-behaviour

Paeds Vivas · growth-development-and-behaviour

School refusal and school attendance problems — branching viva

Branching viva on school refusal formulation, Kearney functions, graded return, CAMS/Melvin evidence, and certificate pitfalls.

branching clinical structured oral
On this page & tools

Target exams

RACP DCEMRCPCH Clinical

Target exams

RACP DCEMRCPCH Clinical
Prompt
Clinic: parents of a 12-year-old with 6 weeks near-complete non-attendance, weekday morning pain, and a request for long-term medical certificates; school may phone mid-station.

Opening

Examiner: Define school refusal for a general paediatrics viva. [1]

Candidate: School refusal is a behaviour, not a freestanding diagnosis: difficulty attending school with emotional distress, usually with caregiver knowledge of the absence. I formulate drivers and maintaining functions rather than coding “school phobia.” [1] [2]

Branch A — Classification

Examiner: How do you distinguish anxious refusal from truancy? [2]

Candidate: Anxious refusal shows distress-driven non-attendance and parents usually know. Truancy is often covert, with less school-related anxiety and more externalising or peer-linked skipping. Egger’s community work shows different psychiatric profiles — so pathways differ. [2]

Examiner: Name Kearney’s four functions. [1]

Candidate: Avoidance of negative affectivity; escape from aversive social/evaluative situations; attention-seeking; tangible reinforcement outside school. Mixed functions are common — I rank them from history, diary, and school collateral. [1]

Branch B — Assessment and risk

Examiner: What must you cover before writing a certificate? [8]

Candidate: Separate child and carer interviews; attendance calendar; medical red flags for somatic symptoms; bullying/safeguarding; developmental/neurodiversity history; mood and suicide risk; school collateral. Anxiety does not protect against suicide. [2] [8]

Probe: Parents demand a three-month certificate. [1]

Candidate: I will not issue open-ended certificates. If short leave is truly needed, it is time-limited and paired with a written reintegration date and graded plan — otherwise I entrench avoidance. [1] [3]

Branch C — Management

Examiner: First-line treatment? [3]

Candidate: Exposure-based CBT with caregiver training: hierarchy, graded school exposures, reduce accommodation, contingency management, school liaison. Attendance goals run in parallel with anxiety treatment. [3] [4]

Probe: When medication? [5]

Candidate: For moderate–severe underlying anxiety or depression, CBT unavailable/ineffective, or combination when impairment is high — not for “school refusal” alone. CAMS supports CBT, sertraline, and especially combination for separation/social/GAD. Melvin: fluoxetine did not clearly beat CBT alone for adolescent school-refusal attendance — I will not overclaim. Counsel activation and suicidality; early review. Example starts: sertraline 25 mg oral daily; fluoxetine 10 mg oral daily, titrate slowly. [5] [6] [7]

Branch D — Stumpers

Examiner: Morning pain vanishes at weekends — what next? [2]

Candidate: Think school-related anxiety pathway after red-flag medical screen. Replace medical shopping with functional analysis and graded return. [2]

Examiner: ASD plus school distress — same plan? [8]

Candidate: Same graded return principles, adapted: sensory plan, visual schedules, predictable transitions. Do not abandon exposure for phobic avoidance, and do not force “just try harder” without load adaptation. [8]

Close

Examiner: One-line take-home. [1]

Candidate: Function first, expose, school this week, SSRI only for the anxiety/mood driver with monitoring — never open-ended certificates. [1] [3] [5]

References

  1. [1]Kearney CA, Albano AM. The functional profiles of school refusal behavior. Diagnostic aspects. Behav Modif, 2004.PMID 14710711
  2. [2]Egger HL, Costello EJ, Angold A. School refusal and psychiatric disorders: a community study. J Am Acad Child Adolesc Psychiatry, 2003.PMID 12819439
  3. [3]King NJ, Tonge BJ, Heyne D, Pritchard M, et al. Cognitive-behavioral treatment of school-refusing children: a controlled evaluation. J Am Acad Child Adolesc Psychiatry, 1998.PMID 9549960
  4. [4]Heyne D, King NJ, Tonge BJ, Rollings S, et al. Evaluation of child therapy and caregiver training in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry, 2002.PMID 12049443
  5. [5]Walkup JT, Albano AM, Piacentini J, Birmaher B, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med, 2008.PMID 18974308
  6. [6]Melvin GA, Dudley AL, Gordon MS, Klimkeit E, et al. Augmenting Cognitive Behavior Therapy for School Refusal with Fluoxetine: A Randomized Controlled Trial. Child Psychiatry Hum Dev, 2017.PMID 27485100
  7. [7]Bridge JA, Iyengar S, Salary CB, Barbe RP, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 2007.PMID 17440145
  8. [8]Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, et al. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry, 2020.PMID 32439401